1. Home
  2. MGYR vs ANTX Comparison

MGYR vs ANTX Comparison

Compare MGYR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.58

Market Cap

115.2M

Sector

Finance

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.65

Market Cap

135.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
ANTX
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
135.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
MGYR
ANTX
Price
$17.58
$3.65
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
8.8K
3.4M
Earning Date
04-29-2026
03-17-2026
Dividend Yield
2.29%
N/A
EPS Growth
26.83
32.56
EPS
0.50
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.52
$1.00
52 Week High
$20.00
$6.91

Technical Indicators

Market Signals
Indicator
MGYR
ANTX
Relative Strength Index (RSI) 52.21 56.34
Support Level $17.07 $1.05
Resistance Level $17.99 $6.91
Average True Range (ATR) 0.42 0.67
MACD 0.02 -0.18
Stochastic Oscillator 80.73 8.98

Price Performance

Historical Comparison
MGYR
ANTX

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: